McKesson price target raised by $80 at Jefferies, here's why

Wound and dermatology-focused Turn Therapeutics set to direct list on the Nasdaq today, 10/8

Cell and Gene Therapies on the Rise: New Report Reveals Growing Adoption and Persistent Challenges

Iterative Health Appoints Bill Kayser as President and Chief Financial Officer

Senior Financial Analyst, FP&A

McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. The Senior Financial Analyst will support the Practice Management Finance team by delivering financial insights, supporting strategic initiatives, and driving performance across the business.

Sign up with Google

Sign in with Google